BPIQ Blog

Jun 23, 20181 min read

GBT's Part A Phase 3 Sickle Cell Data - Any Day Now

Looking forward to Global Blood Therapeutics report out of Part A from their Phase 3 Hope study of their drug voxelotor (formerly GBT440)...

Jump start your biotech due diligence

Our platform helps you uncover your next biotech investment opportunity

bottom of page